炎症标志物对生命体征预测疑似严重感染患者死亡率的附加价值
该研究在471张床位的急性照护医院回顾性纳入2015年4月至2017年3月连续就诊的疑似严重感染成人患者1015例,其中66例(6.5%)死亡。比较基于生命体征(收缩压、呼吸频率、精神状态)的预后模型与额外加入四种炎症标志物(C反应蛋白、中性粒细胞-淋巴细胞比值、平均血小板体积、红细胞分布宽度)的扩展模型预测30天院内死亡率。扩展模型拟合显著更优(似然比检验P<0.001),c指数从0.69(范围0.67-0.70)升至0.76(范围0.75-0.77)(P=0.01);除C反应蛋白外所有标志物对模型改善有显著贡献。在10%风险阈值下,死亡者中9.1%(95%CI -2.8-21.8)被扩展模型正确重分类。作者认为除C反应蛋白外的炎症标志物对生命体征有附加预测价值,未来研究应聚焦于开发和验证包含生命体征与显著标志物的个体化预测模型。
要点
- 在1015例疑似严重感染成人中,30天院内死亡66例(6.5%)。
- 加入炎症标志物的扩展模型c指数0.76(范围0.75-0.77),显著高于生命体征模型的0.69(范围0.67-0.70)(P=0.01)。
- 除C反应蛋白外,中性粒细胞-淋巴细胞比值、平均血小板体积、红细胞分布宽度均对模型改善有显著贡献。
- 在10%风险阈值下,死亡者中仅9.1%(95%CI -2.8-21.8)被扩展模型正确重分类。
- 作者认为除C反应蛋白外的炎症标志物对生命体征有附加预测价值,未来需开发和验证个体化预测模型。
适用人群与场景
- 2015年4月至2017年3月连续就诊于急性照护医院(471张床位)门诊或急诊的疑似严重感染成人患者。
研究设计与关键结果
- 研究类型为回顾性评估,纳入1015例疑似严重感染成人患者,66例(6.5%)发生30天院内死亡。
- 比较基于生命体征(收缩压、呼吸频率、精神状态)的预后模型与额外包含四种炎症标志物(C反应蛋白、中性粒细胞-淋巴细胞比值、平均血小板体积、红细胞分布宽度)的扩展模型。
- 扩展模型拟合显著优于生命体征模型(似然比检验P<0.001)。
- c指数从生命体征模型的0.69(范围0.67-0.70)升至扩展模型的0.76(范围0.75-0.77)(P=0.01)。
- 除C反应蛋白外,其余三种炎症标志物均对模型改善有显著贡献。
- 在10%风险阈值下,死亡者中9.1%(95%CI -2.8-21.8)被扩展模型正确重分类。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为除C反应蛋白外的炎症标志物对生命体征有附加预测价值。
- 作者建议未来研究应聚焦于开发和验证包含生命体征与显著标志物的个体化预测模型。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the added value of inflammatory markers to vital signs to predict mortality in patients suspected of severe infection.
METHODS: This study was conducted at an acute care hospital (471-bed capacity). Consecutive adult patients suspected of severe infection who presented to either ambulatory care or the emergency department from April 2015 to March 2017 were retrospectively evaluated. A prognostic model for predicting 30-day in-hospital mortality based on previously established vital signs (systolic blood pressure, respiratory rate, and mental status) was compared with an extended model that also included four inflammatory markers (C-reactive protein, neutrophil-lymphocyte ratio, mean platelet volume, and red cell distribution width). Measures of interest were model fit, discrimination, and the net percentage of correctly reclassified individuals at the pre-specified threshold of 10% risk.
RESULTS: Of the 1015 patients included, 66 (6.5%) died. The extended model including inflammatory markers performed significantly better than the vital sign model (likelihood ratio test: p < 0.001), and the c-index increased from 0.69 (range 0.67-0.70) to 0.76 (range 0.75-0.77) (p = 0.01). All included markers except C-reactive protein showed significant contribution to the model improvement. Among those who died, 9.1% (95% CI -2.8-21.8) were correctly reclassified by the extended model at the 10% threshold.
CONCLUSIONS: The inflammatory markers except C-reactive protein showed added predictive value to vital signs. Future studies should focus on developing and validating prediction models for use in individualized predictions including both vital signs and the significant markers.
参考来源
- Takada T, Hoogland J, Yano T, et al. Added value of inflammatory markers to vital signs to predict mortality in patients suspected of severe infection. Am J Emerg Med. 2019. PMID: 31859198. doi:10.1016/j.ajem.2019.11.030
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。